Compounds > nelfinavir
Page last updated: 2024-08-24

nelfinavir and Melanoma

nelfinavir has been researched along with Melanoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castiello, L; Ferrari, M; Hiscott, J; Jakobsen, M; Krapp, C; Muscolini, M; Olagnier, D; Palermo, E; Peruzzi, G; Santoni, A; Vulpis, E; Zevini, A; Zingoni, A1
Arozarena, I; Brunton, H; Cooper, ZA; Dummer, R; Ferguson, J; Flaherty, KT; Frederick, DT; Girotti, MR; Lee, JL; Levesque, MP; Marais, R; Miskolczi, Z; Rowling, EJ; Smith, MP; Wargo, JA; Wellbrock, C1
Flaherty, KT; Jiang, W; Lei, H; Mikochik, PJ; Ra, JH; Spitz, FR; Winkler, JD1

Other Studies

3 other study(ies) available for nelfinavir and Melanoma

ArticleYear
An optimized retinoic acid-inducible gene I agonist M8 induces immunogenic cell death markers in human cancer cells and dendritic cell activation.
    Cancer immunology, immunotherapy : CII, 2019, Volume: 68, Issue:9

    Topics: Alarmins; Antigen Presentation; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Calreticulin; Caspase 3; Cell Differentiation; Cell Line, Tumor; DEAD Box Protein 58; Dendritic Cells; HMGB1 Protein; Humans; Immunization; Interferons; Melanoma; Molecular Targeted Therapy; Nelfinavir; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, Immunologic; Signal Transduction

2019
Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy.
    Cancer cell, 2016, Mar-14, Volume: 29, Issue:3

    Topics: Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Tolerance; GTP Phosphohydrolases; HIV Protease Inhibitors; Humans; Melanoma; Membrane Proteins; Mitogen-Activated Protein Kinases; Mutation; Nelfinavir; Paired Box Transcription Factors; PAX3 Transcription Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Up-Regulation

2016
HIV protease inhibitor nelfinavir inhibits growth of human melanoma cells by induction of cell cycle arrest.
    Cancer research, 2007, Feb-01, Volume: 67, Issue:3

    Topics: Apoptosis; cdc25 Phosphatases; Cell Growth Processes; Cell Line, Tumor; Colonic Neoplasms; Cyclin-Dependent Kinase 2; G1 Phase; HIV Protease Inhibitors; Humans; Melanoma; Nelfinavir; Phosphorylation; Proto-Oncogene Proteins c-akt; Retinoblastoma Protein; Signal Transduction

2007